Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Current Assets (2019 - 2025)

Historic Current Assets for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $104.0 million.

  • Benitec Biopharma's Current Assets rose 62400.11% to $104.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $104.0 million, marking a year-over-year increase of 62400.11%. This contributed to the annual value of $51.7 million for FY2024, which is 128573.34% up from last year.
  • Per Benitec Biopharma's latest filing, its Current Assets stood at $104.0 million for Q1 2025, which was up 62400.11% from $78.7 million recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Current Assets ranged from a high of $104.0 million in Q1 2025 and a low of $3.7 million during Q2 2023
  • For the 5-year period, Benitec Biopharma's Current Assets averaged around $28.2 million, with its median value being $16.4 million (2021).
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 7661.1% in 2022, then soared by 128573.34% in 2024.
  • Quarter analysis of 5 years shows Benitec Biopharma's Current Assets stood at $12.7 million in 2021, then dropped by 13.39% to $11.0 million in 2022, then surged by 89.49% to $20.8 million in 2023, then soared by 278.5% to $78.7 million in 2024, then skyrocketed by 32.14% to $104.0 million in 2025.
  • Its Current Assets was $104.0 million in Q1 2025, compared to $78.7 million in Q4 2024 and $68.3 million in Q3 2024.